HCA Holdings, Inc. revised earning guidance for the year 2013. For the year, the company expects its adjusted EBITDA to be approximately $65 million to $75 million above the high-end of its previously issued guidance range of $6.25 billion to $6.50 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
323 USD | +1.29% |
|
+2.38% | +19.28% |
07-12 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
07-09 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.28% | 83.53B | |
-21.58% | 75.4B | |
+2.32% | 26.73B | |
-4.40% | 18.25B | |
+6.95% | 18.12B | |
+7.90% | 16.51B | |
+79.04% | 14.05B | |
+76.17% | 13.03B | |
-27.89% | 12.67B | |
+20.55% | 12.31B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- HCA Holdings, Inc. Revised Earnings Guidance for the Year 2013